The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.

Lebanese-born Armenian-American entrepreneur and philanthropist Noubar Afeyan has joined the likes of the world’s richest man ...

Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

There’s still plenty of room for growth as the AI race continues to unfold. Still, some growth investors are already moving ...

Vladimir Sorokin. Photograph by Maria Sorokina. My problems started much earlier than the night before deadline—they started ...

The CDC declared the end of its emergency response to H5N1 avian flu as a health threat to humans, David Murray writes.

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

A new study suggests a potential link between the Pfizer COVID-19 vaccine and serious eye conditions like retinal vascular ...

TAMPA — Florida’s top health official blasted the manufacturer’s of mRNA COVID-19 vaccines and wants the federal government to do more to help those he described as the “vaccine injured.” Florida ...

When ticks bite us, they release thousands of proteins through their saliva. Could a vaccine for the right ones stop ticks ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...